Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The *left atrium* plays critical roles in cardiac function by acting mechanically as: 1. A reservoir during ventricular systole collecting pulmonary venous return, 2. A conduit during early diastole allowing passive flow into the left ventricle, 3. An active pump during late diastole contributing additional blood volume through contraction[1]. Left atrial compliance affects how well it accommodates incoming blood without excessive rise in *left atrial pressure*—a key determinant of cardiac filling pressures and overall cardiovascular homeostasis[1][5]. Elevated left atrial pressures are commonly seen in conditions like heart failure with preserved ejection fraction where impaired relaxation leads to increased stiffness and higher filling pressures[1][2]. Neurohormonally, stretch of the left atrium stimulates secretion of natriuretic peptides that promote vasodilation and diuresis helping compensate for volume overload states[1][4]. The mechanoreceptors located at venous–atrial junctions also regulate reflexes controlling sympathetic outflow affecting heart rate and vascular tone[3]. Clinically, reduction of elevated *left atrial pressure* aims at improving symptoms related to congestion such as dyspnea while preventing adverse remodeling that predisposes patients to arrhythmias like AFib[2]. This involves pharmacologic interventions targeting preload reduction, afterload reduction, neurohormonal blockade along with device therapies if indicated.
Mechanisms by which drugs reduce LAP include: - Decreasing blood volume/preload via diuresis - Vasodilation lowering systemic vascular resistance and LV filling pressures - Neurohormonal modulation reducing maladaptive cardiac remodeling No direct molecular mechanism applies specifically to "left atrium pressure" since it's an emergent property.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Left atrial pressure (physiological parameter) (LAP).